品質管理
弊社はライフサイエンスにおける研究、開発、製造の世界的なリーディングサプライヤーになるため日々精進しています。我々の目標を達成するためには顧客の皆様の要求を満たす必要があります。 優れた品質と品質保証基準を確立・維持することにより、この目標を実現します。
SelleckはPD1/PDL1治療用抗体の販売を開始しました！（Pembrolizumab，Atezolizumab，Nivolumab）
- ホームページ
- 阻害剤
研究分野別
- PI3K/Akt/mTOR
- Epigenetics
- Methylation
- Immunology & Inflammation
- Protein Tyrosine Kinase
- Angiogenesis
- Apoptosis
- Autophagy
- ER stress & UPR
- JAK/STAT
- MAPK
- Cytoskeletal Signaling
- Cell Cycle
- HTS化合物ライブラリー
- FDA-approved Drug Library
- Preclinical and Clinical Compound Library
- Bioactive Compound Library-I
- Bioactive Compound Library-Ⅱ（Provided by Pfizer）
- Kinase Inhibitor Library
- Express-Pick Library (Provided by Pfizer)
- Natural Product Library
- Human Endogenous Metabolite Library
- Angiogenesis Related compound Library
- Anti-alzheimer's Disease Compound Library
- Antibiotics Library
- Anti-cancer Compound Library
- Anti-cancer Metabolism Compound Library
- Anti-diabetic Compound Library
- Anti-infection Compound Library
- Apoptosis Compound Library
- Autophagy Compound Library
- Cambridge Cancer Compound Library
- Cell Cycle compound library
- CNS-Penetrant Compound Library
- Covalent Inhibitor Library
- DNA Damage/DNA Repair compound Library
- Drug Repurposing Library
- Epigenetics Compound Library
- Fragment Library
- GPCR Compound Library
- Highly Selective Inhibitor Library
- Histone modification compound library
- HTS Library for Drug Discovery (Provided by Pfizer)
- Immunology/Inflammation Compound Library
- Inhibitor Library
- Ion Channel Ligand Library
- JAK/STAT compound library
- MAPK Inhibitor Library
- Metabolism Compound Library
- Neuronal Signaling Compound Library
- NF-κB Signaling Compound Library
- PI3K/Akt Inhibitor Library
- Protease Inhibitor Library
- Small Molecule Immuno-Oncology Compound Library
- Stem Cell Signaling Compound Library
- TGF-beta/Smad compound library
- Tyrosine Kinase Inhibitor Library
- Ubiquitination Related Compound Library
- 治療用抗体
- 新製品
- お問い合わせ
